Abstract
Background/Objective
In 2018 EWGSOP2 has suggested low muscle strength as the primary parameter of sarcopenia. The consensus has recommended SARC-F questionnaire as a screening test to find cases with low muscle strength which has been designated as probable sarcopenia. We aimed to study the ability of SARC-F to find probable sarcopenia cases in older patients.
Design
Retrospective, cross-sectional.
Setting
Istanbul University Istanbul Faculty of Medicine
Participants
A total of 456 older adults (71.1% female, mean age: 74.6±6.6 years)
Measurements
We diagnosed probable sarcopenia by EWGSOP 2 criteria, i.e., presence of low handgrip strength (HGS). SARC-F questionnaire was performed by all participants. We used a receiver operating characteristics curve to obtain SARC-F cut-off values to detect probable sarcopenia and calculated the area under the curve and 95% confidence interval (CI).
Results
We included 456 participants (71.1% female; mean age: 74.6 ± 6.6 years). Probable sarcopenia was present in 58 (12.7%). SARC-F cut-off ≥ 2 presented the best balance between sensitivity and specificity (sensitivity: 64.9% vs specificity: 67.9%) to detect probable sarcopenia [the area under the receiver operating characteristics curve (AUC) = 0.710; 95% Cl: 0.660–0.752, p< 0.001]. SARC-F with a cutoff point ≥ 1 had sensitivity 84.2% and specificity 40.5% and SARC-F ≥ 4 had high specificity 88.2% with 40.3% sensitivity.
Conclusion
SARC-F is a good screening tool for sarcopenia in practice. Our findings suggest SARC-F ≥ 1 cut-off point to be used as the probable sarcopenia screening tool regarding its high sensitivity. Consequently, SARC-F ≥ 4 cut-off is better to be used if one prefers to exclude probable sarcopenia.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010. 39(4): p. 412–23.
Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56.
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sarcopenia%3A+European+consensus+on+definition+and+diagnosis%3A+Report+of+the+European+Working+Group+on+Sarcopenia+in+Older+People&btnG= accessed on September 2020
Cruz-Jentoft AJ, Bahat G, Bauer JM, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019. 48(1): p. 16–31.
Beaudart C, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548
Ida S, Kaneko R, Murata K (2018) SARC-F for screening of sarcopenia among older adults: a meta-analysis of screening test accuracy. J Am Med Dir Assoc 19(8):685–689.
Bahat G, Yilmaz O, Kiliç C, Oren MM, Karan MA (2018) Performance of SARC-F in regard to sarcopenia defnitions, muscle mass and functional measures. J Nutr Health Aging 22(8):898–903
Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630e634.
Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI, et al. Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 2016;17:1142e1146
Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–9.
Lawton MP, Brody EM. Assessment of older people: self-management. Gerontologist 1969;9:179–86
Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996;54:59–65.
Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol: Ser A. 56:366–372. https://doi.org/10.1093/gerona/56.6.m366
Fess EE. Grip strength. In. Casanova JS, ed. Clinical Assessment Recommendations, 41–5.
Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW and Hill CL. Hand Grip Strength: age and gender stratified normative data in a population-based study. BMC Res Notes, 2011. 4: p. 127.
Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 2008;63:160–4.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:85–94
Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012;16:601–608
Dodds RM, Murray JC, Robinson SM, & Sayer AA. (2020). The identification of probable sarcopenia in early old age based on the SARC-F tool and clinical suspicion: findings from the 1946 British birth cohort. European Geriatric Medicine, 1–9.
Sobestiansky, Sigvard, Karl Michaelsson, and Tommy Cederholm. “Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study.” BMC geriatrics 19.1 (2019): 318.
Wearing J, Konings P, de Bie RA, Stokes M, & de Bruin ED. (2020). Prevalence of probable sarcopenia in community-dwelling older Swiss people-a cross-sectional study. BMC Geriatrics, 20(1), 1–8.
Dodds RM, Granic A, Robinson SM, Sayer AA. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J Cachexia Sarcopenia Muscle. 2020;11(1):62–68. doi:https://doi.org/10.1002/jcsm.12503
Lima DP, de Almeida SB, Bonfadini JC, et al. Clinical correlates of sarcopenia and falls in Parkinson’s disease. PLoS One. 2020;15(3):e0227238. Published 2020 Mar 19. doi:https://doi.org/10.1371/journal.pone.0227238
Kirk B, Phu S, Brennan-Olsen SL, Bani Hassan E, Duque G. Associations between osteoporosis, the severity of sarcopenia and fragility fractures in community-dwelling older adults. Eur Geriatr Med. 2020;11(3):443–450. doi:https://doi.org/10.1007/s41999-020-00301-6
Mazocco L, Chagas P, Barbosa-Silva TG, Gonzalez MC, Schwanke CHA. Accuracy of SARC-F and SARC-CalF for Sarcopenia screening in older women from southern Brazil. Nutrition. 2020;79–80:110955. doi:https://doi.org/10.1016/j.nut.2020.110955
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest: There are no other relationships/conditions/circumstances that present a potential conflict of interest.
Ethical standards: The study was conducted according to guidelines in the Declaration of Helsinki. The study was approved from the local ethic committee (No:1707).
Additional information
Statement of Authorship: Mehmet Akif Karan: Supervision, Reviewing and Editing. Cihan Kilic: Data curation. Duygu Erbas Sacar: Writing- Original draft preparation, Writing- Reviewing and Editing. Gulistan Bahat: Conceptualization, Methodology, Software, Validation, Writing- Reviewing and Editing, Supervision.
Sponsor’s role: None.
This study was presented as a ‘poster presentation’ in 15th EuGMS Congress held in Kraków, Poland in 2019.
Rights and permissions
About this article
Cite this article
Sacar, D.E., Kilic, C., Karan, M.A. et al. Ability of SARC-F to Find Probable Sarcopenia Cases in Older Adults. J Nutr Health Aging 25, 757–761 (2021). https://doi.org/10.1007/s12603-021-1617-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-021-1617-3